trastuzumab deruxtecan,ruxolitinib
novartis,daiichi sankyo,astrazeneca,incyte
['rectal', 'rux,(-crux),(-trux)', 'colorectal', 'trastuzumab deruxtecan']
our dr. kanwal raghav presented at #asco23 a study he led that demonstrated promising antitumor activity with the use of trastuzumab deruxtecan for patients with her2-positive metastatic colorectal cancer. #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789